Status: Not yet recruiting
Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital
Prevelance of axial spondylosis arthritis in inflammatory bowel disease and its RESPONSE to tumour necrosis factor (TNF) inhibitors TREATMENT
Participants needed: 100
Trial details
Age: 18-60Biological sex: AllType: ObservationalSponsor: Mohamed NasrUpdated: Sep 19, 2024
Eligibility criteria
Not listed